These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1613 related articles for article (PubMed ID: 21633179)

  • 41. Nutritional approaches for managing obesity-associated metabolic diseases.
    Botchlett R; Woo SL; Liu M; Pei Y; Guo X; Li H; Wu C
    J Endocrinol; 2017 Jun; 233(3):R145-R171. PubMed ID: 28400405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adipocyte Ceramides-The Nexus of Inflammation and Metabolic Disease.
    Chaurasia B; Talbot CL; Summers SA
    Front Immunol; 2020; 11():576347. PubMed ID: 33072120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrophages, inflammation, and insulin resistance.
    Olefsky JM; Glass CK
    Annu Rev Physiol; 2010; 72():219-46. PubMed ID: 20148674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.
    Kang YS; Cha JJ; Hyun YY; Cha DR
    Expert Opin Investig Drugs; 2011 Jun; 20(6):745-56. PubMed ID: 21466412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Adipose tissue secretory function: implication in metabolic and cardiovascular complications of obesity].
    Guerre-Millo M
    J Soc Biol; 2006; 200(1):37-43. PubMed ID: 17144160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle.
    Silvestri C; Ligresti A; Di Marzo V
    Rev Endocr Metab Disord; 2011 Sep; 12(3):153-62. PubMed ID: 21336842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypothalamic inflammation and malfunctioning glia in the pathophysiology of obesity and diabetes: Translational significance.
    Rahman MH; Bhusal A; Lee WH; Lee IK; Suk K
    Biochem Pharmacol; 2018 Jul; 153():123-133. PubMed ID: 29337002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Innate immune activation in obesity.
    Lumeng CN
    Mol Aspects Med; 2013 Feb; 34(1):12-29. PubMed ID: 23068074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tartary Buckwheat Extract Attenuated the Obesity-Induced Inflammation and Increased Muscle PGC-1a/SIRT1 Expression in High Fat Diet-Induced Obese Rats.
    Kim SY; Lee MS; Chang E; Jung S; Ko H; Lee E; Lee S; Kim CT; Kim IH; Kim Y
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30889894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.
    Cao Y
    Nat Rev Drug Discov; 2010 Feb; 9(2):107-15. PubMed ID: 20118961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PPARs in diseases: control mechanisms of inflammation.
    Kostadinova R; Wahli W; Michalik L
    Curr Med Chem; 2005; 12(25):2995-3009. PubMed ID: 16378501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adipose tissue inflammation and ectopic lipid accumulation.
    Suganami T; Tanaka M; Ogawa Y
    Endocr J; 2012; 59(10):849-57. PubMed ID: 22878669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.
    Komori T; Tanaka M; Furuta H; Akamizu T; Miyajima A; Morikawa Y
    Diabetologia; 2015 Aug; 58(8):1868-76. PubMed ID: 25972231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diet-induced hypothalamic dysfunction and metabolic disease, and the therapeutic potential of polyphenols.
    Samodien E; Johnson R; Pheiffer C; Mabasa L; Erasmus M; Louw J; Chellan N
    Mol Metab; 2019 Sep; 27():1-10. PubMed ID: 31300352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. n-3 fatty acids modulate adipose tissue inflammation and oxidative stress.
    Fan C; Zirpoli H; Qi K
    Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):124-32. PubMed ID: 23222801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PPARs as drug targets to modulate inflammatory responses?
    Genolet R; Wahli W; Michalik L
    Curr Drug Targets Inflamm Allergy; 2004 Dec; 3(4):361-75. PubMed ID: 15584886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liver.
    Gerner RR; Wieser V; Moschen AR; Tilg H
    Can J Physiol Pharmacol; 2013 Nov; 91(11):867-72. PubMed ID: 24117253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation, obesity, and the promise of immunotherapy for metabolic disease.
    O'Rourke RW
    Surg Obes Relat Dis; 2013; 9(5):609-16. PubMed ID: 22959472
    [No Abstract]   [Full Text] [Related]  

  • 59. Inflammation and metabolic dysfunction: links to cardiovascular diseases.
    Taube A; Schlich R; Sell H; Eckardt K; Eckel J
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2148-65. PubMed ID: 22447947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha in muscle links metabolism to inflammation.
    Handschin C
    Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1139-43. PubMed ID: 19671064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 81.